The Northwestern University Transgenic and Targeted Mutagenesis Laboratory (TTML) is a shared resource designed to produce genetically engineered mice for research projects of investigators ofthe Robert H Lurie Comprehensive Cancer Center (RHLCCC), Feinberg School of Medicine (FSM), Evanston campus, and Lurie Children's Hospital of Chicago Research Center. The transgenic facility was initially founded at Northwestern University in 1989, as part ofthe Markey Program in Developmental Biology, to provide a resource for generating transgenic mice. Today, the facility has evolved into a well utilized laboratory that provides a broad range of services to NU investigators, including generation of transgenic mice, gene targeting of embryonic stem (ES) cells, generation of chimeric mice via ES cell microinjection into blastocysts, cryopreservation and recovery of mouse embryos/sperm, and rederivation of pathogen free mouse strains. In 2003, the facility was reorganized and expanded to include gene targeting services. Embryo cryopreservation and recovery, rederivation of mouse lines, and in vitro fertilization services were added in 2005. The embryo, and now sperm, cryopreservation and recovery services position NU and Cancer Center investigators to capitalize on emerging repositories of mutant mice generated around the world, most of which are stored as cryopreserved embryos. Innovative genome editing technologies have been introduced over the last 18 months. These technologies implore zinc finger nuclease (ZFN) and recombinase mediated cassette exchange (RMCE) mechanisms to create gene-specific modifications directly in the zygote via pronuclear microinjection. Cancer Center investigators save both monetary resources and time as these technologies eliminate the need for ES cell based gene targeting. The TTML provides the necessary infrastructure that allows most investigators access to transgenic technology that normally requires expensive microinjection equipment and highly skilled staff with expertise in microinjection, microsurgeries, embryo manipulation, animal husbandry, and ES cell culture. TTML staff provides consultation and guidance regarding transgenic and targeting vector design;appropriate screening strategies;DNA purification methods;breeding and analysis of transgenic founder and chimeric mice;and transgenic-related technologies. The oversight committee that governs the TTML meets at least twice a year and is comprised of a dynamic group of faculty with a wide range of transgenic-related expertise. They critically review facility data/progress and provide astute advice. Since the inclusion ofthe TTML as a resource within the Cancer Center in 1995, Cancer Center investigators have consistently been the primary group of NU investigators utilizing the TTML, emphasizing its pivotal role in the overall research mission ofthe RHLCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA060553-19
Application #
8588648
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2018-07-31
Budget Start
2013-09-16
Budget End
2014-07-31
Support Year
19
Fiscal Year
2013
Total Cost
$139,029
Indirect Cost
$49,090
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Caralt, M; Uzarski, J S; Iacob, S et al. (2015) Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 15:64-75
Hung, Andy H; Holbrook, Robert J; Rotz, Matthew W et al. (2014) Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano 8:10168-77
Gach, Johannes S; Achenbach, Chad J; Chromikova, Veronika et al. (2014) HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study. PLoS One 9:e85371
Zhao, Baobing; Keerthivasan, Ganesan; Mei, Yang et al. (2014) Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica 99:1157-67
Keller, Jacob Pearson; Homma, Kazuaki; Duan, Chongwen et al. (2014) Functional regulation of the SLC26-family protein prestin by calcium/calmodulin. J Neurosci 34:1325-32
Daugherty, Rebecca L; Serebryannyy, Leonid; Yemelyanov, Alex et al. (2014) ?-Catenin is an inhibitor of transcription. Proc Natl Acad Sci U S A 111:5260-5
Jensen, Samuel A; Calvert, Andrea E; Volpert, Giora et al. (2014) Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A 111:5682-7
Cull, Elizabeth H; Altman, Jessica K (2014) Contemporary treatment of APL. Curr Hematol Malig Rep 9:193-201
Anderson, Mark T; Dewenter, Lena; Maier, Berenike et al. (2014) Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio 5:e01004-13
Gopal, Satish; Achenbach, Chad J; Yanik, Elizabeth L et al. (2014) Moving forward in HIV-associated cancer. J Clin Oncol 32:876-80

Showing the most recent 10 out of 316 publications